Inovio Pharmaceuticals
INO
#8784
Rank
A$0.23 B
Marketcap
A$3.45
Share price
-3.80%
Change (1 day)
16.16%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): A-$4.35

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$4.35. In 2024 the company made an earnings per share (EPS) of A-$5.97 an increase over its 2023 EPS that were of A-$9.21.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$4.35-27.2%
2024A-$5.97-35.14%
2023A-$9.21-56.62%
2022A-$21.23-19.54%
2021A-$26.3835.9%
2020A-$19.41-11.57%
2019A-$21.9515.24%
2018A-$19.05-2.78%
2017A-$19.596.93%
2016A-$18.32134.88%
2015A-$7.80-29.51%
2014A-$11.07-57.34%
2013A-$25.94146.55%
2012A-$10.5220.83%
2011A-$8.71-29.41%
2010A-$12.34-48.48%
2009A-$23.9510%
2008A-$21.7711.11%
2007A-$19.59-41.3%
2006A-$33.38-66.91%
2005A-$100.87110.61%
2004A-$47.90-61.63%
2003A-$124.82186.67%
2002A-$43.54
2001N/A-100%
2000A-$34.83-63.64%
1999A-$95.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$2.60-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$15.78-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A-$1.89-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$11.13-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$11.48-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$5.44-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
A$9.86-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA